ARCHIVES

Gleevec Better Than Interferon For Newly Diagnosed CML

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Advises Five-Year Limit On Tamoxifen Use, in Letter To Doctors

December 8, 1995

NCI Makes First NRS Award – 13 Institution Grants; 150 Individuals Pending: Lepovetsky Training Chief

April 4, 1975

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

December 29, 2006

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

Duke Physician, BM, Patients, Lobby For Reimbursement

October 22, 1993

Case Western Wins Renewal.

October 5, 2001